Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradationSatoshi Yamanaka, Tatsuya Sawasaki|Nature Communications|2023Cited by 58
An IMiD-induced SALL4 degron system for selective degradation of target proteinsSatoshi Yamanaka, Tatsuya Sawasaki|Communications Biology|2020Cited by 31
PLZF is a new substrate of CRBN with thalidomide and 5-hydroxythalidomideSatoshi Yamanaka, Tatsuya Sawasaki|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 5